The Global dermatology devices market is projected to reach USD 32.31 billion by 2030 from USD 17.25 billion in 2024, growing at 11.2% CAGR due to rising skin disorders.
The global dermatology devices industry has emerged as a dynamic and rapidly expanding sector within the broader medical device and aesthetic care market. This growth is being fueled by a confluence of factors, including rising awareness of skin health, increasing incidence of dermatological disorders, a growing desire for cosmetic enhancement, and continual technological advancements. Dermatology devices encompass a broad range of equipment used for diagnosis, treatment, and aesthetic procedures related to skin, hair, and nails. These include diagnostic devices like dermatoscopes and imaging systems, as well as treatment devices such as lasers, light therapy equipment, cryotherapy tools, and microdermabrasion machines. As consumers become more conscious of both medical and cosmetic aspects of dermatology, the industry is witnessing unprecedented interest from healthcare providers, clinics, and even home-use device manufacturers. One of the most significant growth drivers in the dermatology devices market is the increasing prevalence of skin diseases such as acne, psoriasis, eczema, rosacea, and skin cancer. These conditions affect millions globally and demand prompt, non-invasive, and precise diagnostic and treatment solutions. In parallel, the aging global population is contributing to a rise in demand for anti-aging treatments and skin rejuvenation procedures. This has led to a surge in the adoption of energy-based devices—such as lasers and radiofrequency systems—that offer minimally invasive solutions with quick recovery times. Patients today prefer aesthetic dermatological treatments that are safe, effective, and require minimal downtime, which has opened the door for innovations in device design, ergonomics, and portability. Additionally, the integration of artificial intelligence (AI) in diagnostic imaging tools is making skin condition detection faster and more accurate, further expanding the scope of dermatology practices. According to the research report “Global Dermatology Devices Market Outlook, 2030” published by Bonafide Research, the global market is projected to reach market size of USD 32.31 Billion by 2030 increasing from USD 17.25 Billion in 2024, growing with 11.26% CAGR by 2025-30. The dermatology devices industry is also experiencing significant traction in the cosmetic and aesthetic segment, driven by the increasing desire for youthful, flawless skin and growing social media influence. Procedures like tattoo removal, scar reduction, pigmentation correction, skin tightening, and hair removal are increasingly performed using technologically advanced devices. The non-invasive nature of these treatments makes them attractive to a wide demographic, including millennials and Gen Z, who are more willing to spend on self-care and appearance enhancement. This cultural shift has not only increased patient volume at dermatology clinics and medspas but also encouraged the development of compact, user-friendly devices for at-home use—especially in mature markets like North America and Europe. From a regional perspective, North America holds the largest share in the dermatology devices market, owing to high healthcare spending, advanced infrastructure, and strong consumer demand for both medical and cosmetic dermatological services. However, the Asia-Pacific region is rapidly catching up due to rising disposable income, increased awareness of skin conditions, and a growing number of dermatology clinics across urban centers. Countries like China, India, South Korea, and Japan are emerging as significant markets, driven by lifestyle changes, a beauty-conscious population, and government support for healthcare innovation. Moreover, the region is becoming a hub for affordable aesthetic procedures, attracting medical tourism and further boosting the demand for dermatology devices.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample| By Product | Dermatology diagnostics devices, by Type | |
| Dermatology treatment devices, by Type | ||
| By Application | Skin Cancer Diagnosis & Treatment | |
| Wrinkle Treatment / Anti-aging | ||
| Scar & Stretch Mark Treatment | ||
| Acne, Psoriasis, Rosacea | ||
| Hair Removal | ||
| Others(hyperpigmentation, melasma, vitiligo, scar revision, stretch marks) | ||
| By End User | Hospitals | |
| Clinics | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Dermatology treatment devices are leading the dermatology devices market due to the surging demand for aesthetic procedures and advanced, non-invasive treatment options for both medical and cosmetic skin conditions. Dermatology treatment devices have emerged as the dominant segment within the dermatology devices market largely because of the increasing preference for non-invasive or minimally invasive procedures that address a wide range of skin issues—from acne and pigmentation to wrinkle reduction and hair removal. The rise in lifestyle-related skin problems, combined with greater awareness of appearance and self-care, has fueled demand for laser therapy, light-based devices, microdermabrasion, and cryotherapy units. These devices not only offer visible and long-lasting results but also require minimal recovery time, making them appealing to patients across all age groups. In addition, growing medical needs such as skin cancer treatment, vascular lesion removal, and psoriasis management have expanded the clinical application of treatment devices. Technological advancements have further enhanced their safety, precision, and ease of use, encouraging their widespread adoption in dermatology clinics, aesthetic centers, and even home settings. As the global population continues to age and the cultural acceptance of cosmetic dermatology broadens, treatment devices remain central to both medical dermatology and beauty-focused practices—making them the market's most in-demand and revenue-generating category. Skin cancer diagnosis and treatment is leading the dermatology devices market due to the rising global incidence of skin cancer and the growing emphasis on early detection and precision treatment technologies. Skin cancer diagnosis and treatment has become the most dominant application within the dermatology devices market, primarily because of the alarming rise in the number of skin cancer cases worldwide—particularly melanoma and non-melanoma cancers such as basal cell carcinoma and squamous cell carcinoma. Increasing exposure to harmful UV radiation, lifestyle changes, and greater awareness through screening campaigns have led to higher rates of skin cancer detection, prompting a strong demand for reliable, advanced diagnostic and therapeutic tools. Devices such as dermatoscopes, digital imaging systems, and laser treatment units have become essential in identifying cancerous lesions early, often before they become life-threatening. Furthermore, non-invasive and precise treatment technologies like cryosurgery, photodynamic therapy, and radiofrequency ablation offer effective options with minimal side effects and downtime. The prioritization of early diagnosis not only improves patient outcomes but also reduces long-term healthcare costs, which is why healthcare systems and dermatology clinics are investing heavily in advanced diagnostic and treatment infrastructure. This surge in both incidence and awareness, paired with continual technological evolution in dermatologic oncology tools, firmly places skin cancer care at the forefront of the dermatology devices market. Hospitals are leading the dermatology devices market due to their comprehensive infrastructure, skilled personnel, and ability to offer both advanced diagnostic and therapeutic dermatologic services under one roof. Hospitals hold the leading position in the dermatology devices market primarily because they provide integrated care, combining state-of-the-art diagnostic equipment with a wide range of treatment options for skin conditions, including complex diseases like skin cancer, chronic inflammatory disorders, and severe infections. These institutions are typically equipped with high-end devices such as dermatoscopes, cryotherapy units, laser systems, and radiofrequency machines that require significant capital investment and specialized operation—capabilities more commonly found in hospitals than in smaller clinics or ambulatory centers. Moreover, hospitals are staffed with trained dermatologists, oncologists, and technicians who can perform advanced procedures, manage complications, and offer multidisciplinary care. Their access to broader funding, institutional partnerships, and medical research also supports the adoption of cutting-edge technologies. Additionally, hospitals often serve as referral centers for patients with severe or rare dermatological conditions, further increasing patient footfall and device utilization. As patient trust remains high in hospital settings for complex and critical treatments, and as healthcare systems expand their dermatology departments, hospitals continue to dominate in both procedural volume and revenue generation within the dermatology devices market.
to Download this information in a PDF
North America is leading the dermatology devices market due to its advanced healthcare infrastructure, high awareness of skin health and aesthetics, and strong adoption of cutting-edge technologies. North America dominates the global dermatology devices market largely because of its well-established healthcare systems, high per capita healthcare spending, and early adoption of technological advancements in medical and aesthetic dermatology. The region, particularly the United States, experiences a high prevalence of skin disorders such as melanoma, psoriasis, and acne, driving demand for both diagnostic and therapeutic dermatology devices. In addition, a culturally ingrained emphasis on physical appearance and youthfulness has led to a booming aesthetic dermatology sector, with increasing demand for non-invasive procedures like laser treatments, body contouring, and anti-aging solutions. The presence of a large number of dermatology clinics, cosmetic centers, and hospitals equipped with advanced devices—alongside a significant pool of trained dermatologists—further supports widespread device utilization. North America also benefits from favorable reimbursement policies, ongoing R&D activities, and the presence of key market players who launch innovative products tailored to regional consumer needs.
to Download this information in a PDF
• In July 2023, Canfield Scientific had announced the 25th World Congress of Dermatology, which was held from the 4th to the 7th of July at the Suntec Singapore Convention & Exhibition Centre. It comprised in-person demonstrations of its advanced and latest dermatology devices and solutions, including IntelliStudio, VEOS, DermaGraphix, and VECTRA WB360. • In April 2023, Canfield Scientific was certified to both ISO 9001:2015 and ISO 13485:2016 standards for its quality management system. • In February 2023, Candela Corporation, a global manufacturer of medical aesthetic devices announced that the dual-wavelength Frax Pro non-ablative fractional laser platform and the Nordlys multi-application platform with Selective Waveband Technology (SWT) were licensed and made available by Health Canada.

We are friendly and approachable, give us a call.